p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women (Q36361863)

13 August 2017

p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women (English)

1 reference

13 August 2017

1 reference

1

Nicolas Wentzensen

1 reference

13 August 2017

4

Mark Schiffman

1 reference

13 August 2017

3

Philip E Castle

1 reference

13 August 2017

Barbara Fetterman

2

1 reference

13 August 2017

Shannon N Wood

5

1 reference

13 August 2017

Eric Stiemerling

6

1 reference

13 August 2017

Diane Tokugawa

7

1 reference

13 August 2017

Clara Bodelon

8

1 reference

13 August 2017

Nancy Poitras

9

1 reference

13 August 2017

Thomas Lorey

10

1 reference

13 August 2017

Walter Kinney

11

1 reference

13 August 2017

language of work or name

English

0 references

publication date

15 September 2015

1 reference

Journal of the National Cancer Institute

13 August 2017

1 reference

13 August 2017

107

1 reference

13 August 2017

12

1 reference

13 August 2017

djv257

1 reference

Multiple biopsies and detection of cervical cancer precursors at colposcopy

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4675094

Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4675094

Screening for cervical cancer precursors with p16/Ki-67 dual-stained cytology: results of the PALMS study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4675094

Benchmarking CIN 3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4675094

2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4675094

Triage of HPV-positive women in cervical cancer screening

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4675094

Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4675094

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4675094

Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4675094

Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4675094

Human papillomavirus testing in the prevention of cervical cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4675094

HPV screening for cervical cancer in rural India

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4675094

Five-year experience of human papillomavirus DNA and Papanicolaou test cotesting

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4675094

Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4675094

Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4675094

Interlaboratory variation in the performance of liquid-based cytology: insights from the ATHENA trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4675094

Interobserver reproducibility and accuracy of p16/Ki-67 dual-stain cytology in cervical cancer screening

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4675094

Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested substudy of the NTCC randomised controlled trial.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4675094

Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dual-stained cytology.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4675094

A virtual microscopy system to scan, evaluate and archive biomarker enhanced cervical cytology slides.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4675094

Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4675094

Overview of the European and North American studies on HPV testing in primary cervical cancer screening

22 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV257

Comparisons of predictive values of binary medical diagnostic tests for paired designs

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26376685

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26376685

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26376685

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/JNCI/DJV257

1 reference

13 August 2017

1 reference

13 August 2017

PubMed publication ID

26376685

1 reference